Bitter Pill: Merck To Cut 7,000 More Jobs

Merck, one of the country's biggest pharmaceutical makers, announced Wednesday it is slashing more than 7,000 positions, or 12 percent of its global work force. Those cuts come on top of more than 10,000 jobs that were eliminated in an earlier restructuring. The new cuts were announced as the company reported a sharp drop in income for the recent quarter, due partly to lower sales of the cholesterol drugs Vytorin and Zetia.

Merck also faces competition from generic drugmakers as patents on top-selling medications expire. Rival drug company Pfizer faces the same problem. The maker of top-selling cholesterol drug Lipitor already has cut more than 14,000 jobs since last year, and workers there are bracing for more.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: